Proposed ACA replacement intensifies US health debate

23 June 2017
ussenate-big

Republicans have taken the chance to aim further criticism at the Affordable Care Act (ACA) amid US Senate proposals to repeal and replace the act.

The ACA, popularly known as Obamacare as it was introduced by the previous President Barack Obama, has been labelled a failure by his successor, Donald Trump, although the attempts of the Republican leader and his colleagues to come up with an alternative have been somewhat protacted.

On Thursday, Republican party leaders unveiled their proposed replacement with the Better Care Reconciliation Act of 2017. It comes after the House of Representatives passed proposals last month.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical